Butylphthalide for Brain Edema After Endovascular Treatment
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 100 participants.
Also called NCT07528456
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 100 participants
- Registry
-
NCT07528456
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07528456. Randomized; quadruple masking; primary purpose treatment. Start 2026-04-01 (anticipated); primary completion 2027-04 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Butylphthalide for Brain Edema After Endovascular Treatment
- Condition
- Acute Ischemic Stroke
- Intervention (Drug)
- Butylphthalide
- Intervention (Drug)
- Placebo
- Lead sponsor
- Nanfang Hospital, Southern Medical University
Record details
- Record id
cardio:ct-nct07528456- Content hash
9383f4ee4edb92b4db39e97f3e996714b9b46035fb6141672716c36caec766ee